Results 141 to 150 of about 21,962 (187)
Peripheral Blood Skin-Homing T Cells Define Immunological Endotypes in Atopic Dermatitis: A Case-Control Study in a Mexican Population. [PDF]
Luis Carlos ZP +6 more
europepmc +1 more source
Regulatory T cells in breast cancer drivers of immune suppression and targets for immunotherapy. [PDF]
Pan T +5 more
europepmc +1 more source
Adult T-cell leukemia/lymphoma: molecular pathogenesis, emerging therapies, and future directions. [PDF]
Samaha Y, Hugo H, Asrani R.
europepmc +1 more source
Of the nine known members of the CCR4-NOT complex, CCR4/CAF1 are most important in mRNA dead-enylation whereas the NOT1-5 proteins are most critical for transcriptional repression. Whole genome microarray analysis using deletions in seven of the CCR4-NOT
Clyde L Denis +2 more
exaly +2 more sources
CCR4 as a Therapeutic Target for Cancer Immunotherapy [PDF]
CCR4 is a chemokine receptor mainly expressed by T cells. It is the receptor for two CC chemokine ligands, CCL17 and CCL22. Originally, the expression of CCR4 was described as highly selective for helper T type 2 (Th2) cells. Later, its expression was extended to other T cell subsets such as regulatory T (Treg) cells and Th17 cells.
Osamu Yoshie
exaly +3 more sources
PABP Cooperates With the CCR4-NOT Complex to Promote mRNA Deadenylation and Block Precocious Decay
Multiple deadenylases are known in vertebrates, the PAN2-PAN3 (PAN2/3) and CCR4-NOT (CNOT) complexes, and PARN, yet their differential functions remain ambiguous. Moreover, the role of poly(A) binding protein (PABP) is obscure, limiting our understanding
Joha Park, Vic Narry Kim, Jaechul Lim
exaly +3 more sources
The CCR4 transcriptional regulatory complex consisting of CCR4, CAF1, DBF2 and other unidentified factors is one of several groups of proteins that affect gene expression. Using mass spectrometry, we have identified the 195, 185 and 116 kDa species which
Juri Rappsilber +2 more
exaly +2 more sources
Diphtheria-Toxin Based Anti-Human CCR4 Immunotoxin for Targeting Human CCR4+ Cells in Vivo [PDF]
CC chemokine receptor 4 (CCR4) has attracted much attention as a promising therapeutic drug target for CCR4+ tumor cells and Tregs. CCR4 is expressed on some tumor cells such as T‐cell acute lymphoblastic leukemia (ALL), adult T‐cell leukemia/lymphoma (ATLL), adult peripheral T cell lymphoma (PTCL) and cutaneous T cell lymphoma (CTCL).
David H Sachs +2 more
exaly +4 more sources

